Introduction/purpose Dissecting pseudoaneurysms (DPAs) are rare but challenging entities, with significant reported mortality and morbidity. However, we believe the cervical or intracranial but extradural dissecting pseudoaneurysms are a different entity.
Methods Institutional Review Board approval was obtained for this study. Retrospective review of our database containing 943 patients with aneurysm treatment between 2001–2015 was reviewed. Inclusion Criteria: All patients with spontaneous or traumatic cervical or intracranial extradural dissecting pseudoaneurysms (DPAs). Exclusion Criteria: 1) Intradural dissecting pseudoaneurysms (DPAs); 2) Isolated intracranial dissection with no associated pseudoaneurysm; 3) Infective (Mycotic) pseudoaneurysms; 4) Pseudoaneurysms related to oropharyngeal tumoral infiltration.
Patient demographics, clinical presentation, aneurysm characteristics, treatment details, complications and outcomes based on follow-up imaging and clinical information were collected from the database. Procedure modalities and treatment outcome were collected from patient chart. Follow-up imaging used MRA or DSA or both. Clinical outcome was evaluated at the last known clinical follow-up based on modified Rankin Score (mRS).
Results A total of 14 patients (M:F = 8:6) with 14 DPAs constituted our study population. The mean age was 55.9 ± 17.2 years (range: 18–81 years). Six patients (43%) had traumatic DPAs (1: Gunshot injury and 5: Motor vehicle accident), 5 patients (36%) had iatrogenic injury (2: Cervical spine internal fixation; 2: Pituitary adenoma resection and 1: Planum sphenoidale meningioma resection) and 3 patients (21%) had spontaneous dissection. Seven patients (50%) had ischemic presentation from distal emboli or focal neurologic deficit. None had hemorrhagic presentation.
DPAs were equally distributed in the anterior and posterior circulation. Mean DPA diameter was 4.7 ± 3.2 mm (range: 2.0–15 mm).
Parent vessel occlusion (PVO) was the most commonly used treatment modality (79%; n = 11) with variable use of coils (n = 7), Amplatzer occlusion device (n = 1) or both (n = 3). Three patients had vessel preservation approach using coils (n = 1), stenting (n = 1) and the combination of both (n = 1). There were no technical or procedural complications. The median hospital length of stay was 7 days.
The median short-term angiographic follow-up was 42 ± 22 days (2–79 days). The median long-term angiographic follow-up was 16.5 ± 16.7 months (0–65 months). Two patients (14%) were lost for long-term follow-up. All the patients had complete obliteration of the DPAs; parent vessel remained obliterated in patients with parent vessel occlusion at both short and long-term follow-up. No patients required a repeat treatment.
The mean last known clinical follow-up was 23.3 ± 25.1 months. Two patients (14%) were lost to clinical follow-up. Nine patients (75%) had mRS score of ≤ 1 and 3 patients (25%) had mRS of 2.
Conclusions Parent vessel occlusion (PVO) is a feasible, safe and reliable treatment option for cervical or intracranial extradural dissecting pseudoaneurysms with an excellent clinical outcome and no evidence of recanalization at long-term follow-up.
Disclosures S. Boddu: None. D. Kimball: None. M. Crimmins: None. A. Banihashemi: None. J. Knopman: None. A. Patsalides: None. P. Gobin: None.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.